Cite
Kawabata M, Yokoyama Y, Sasaki T, et al. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clin Pharmacol. 2015;7:29-36doi: 10.2147/CPAA.S77021.
Kawabata, M., Yokoyama, Y., Sasaki, T., Tao, S., Ihara, K., Shirai, Y., Sasano, T., Goya, M., Furukawa, T., Isobe, M., & Hirao, K. (2015). Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clinical pharmacology : advances and applications, 729-36. https://doi.org/10.2147/CPAA.S77021
Kawabata, Mihoko, et al. "Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers." Clinical pharmacology : advances and applications vol. 7 (2015): 29-36. doi: https://doi.org/10.2147/CPAA.S77021
Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, Sasano T, Goya M, Furukawa T, Isobe M, Hirao K. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clin Pharmacol. 2015 Feb 16;7:29-36. doi: 10.2147/CPAA.S77021. eCollection 2015. PMID: 25733934; PMCID: PMC4337503.
Copy
Download .nbib